Natural protein points to new inflammation treatment

Natural protein points to new inflammation treatment
Stained sections of foot joints from wild-type (left) and TTP+ (right) mice show that when both were tested using a model of rheumatoid arthritis, the wild-type mouse experienced significant inflammation. Arrows indicate the presence of inflammatory immune cells in tissues lining the joints. The mouse with higher amounts of TTP did not exhibit inflammation. Credit: NIEHS

Increasing the level of a naturally-produced protein, called tristetraprolin (TTP), significantly reduced or protected mice from inflammation, according to researchers at the National Institutes of Health. The results suggest that pharmaceutical compounds or other therapeutic methods that produce elevated levels of TTP in humans may offer an effective treatment for some inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis. The report appeared online Feb. 1 in the Proceedings of the National Academy of Sciences.

Inflammation has been proven to play a major role in a number of normal processes in humans, but it also fosters diseases, many of which are increasing in prevalence and severity. The development of new therapies for treating could greatly reduce the growing health burden.

With this goal in mind, Perry Blackshear, M.D., D.Phil., a researcher at the National Institute of Environmental Health Sciences (NIEHS), part of NIH, led the team that genetically altered the TTP gene in mice, so that the animals produced higher than normal amounts of the TTP protein. The mice were then tested using experimental models of , psoriasis, and . Experimental models are used to study processes thought to be involved in human diseases, and to evaluate and select therapies that affect these processes.

"Mice with more TTP in their bodies were resistant to the that accompanied these of disease," Blackshear said. "We also found evidence of how TTP is providing this protection."

Blackshear said TTP exerts its beneficial effect by targeting several messenger molecules that encode cytokines, proteins known to be involved in inflammation. TTP binds to these molecules and destabilizes them, resulting in lower levels of cytokines and, thus, decreased inflammation.

Blackshear anticipates that TTP-based treatments would be cost effective and easy to administer. Future work will seek to identify compounds that have similar effects on the levels of TTP in the body.

"Many current therapies for these inflammatory diseases are expensive and require the medicines be introduced into the body under the skin, in the muscle, or by intravenous injection," said Sonika Patial, D.V.M., Ph.D., a research fellow in Blackshear's research group and lead author on the paper. "Our ideal treatments would be administered orally in pill or liquid form."


Explore further

Birds appear to lack important anti-inflammatory protein

More information: Sonika Patial et al. Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies, Proceedings of the National Academy of Sciences (2016). DOI: 10.1073/pnas.1519906113
Citation: Natural protein points to new inflammation treatment (2016, February 4) retrieved 11 December 2019 from https://medicalxpress.com/news/2016-02-natural-protein-inflammation-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
102 shares

Feedback to editors

User comments